ProfileGDS5678 / 1455463_at
TitleAnti-VEGF and Anti-Notch treatment effect on U87 glioblastoma xenograft tumors [Mouse430_2]
OrganismMus musculus


control bevacizumab dibenzazepine GSM967852 GSM967853 GSM967854 GSM967855 GSM967856 GSM967862 GSM967863 GSM967864 GSM967865 GSM967857 GSM967858 GSM967859 GSM967860 GSM967861 45% 45% 45% 44% 44% 46% 46% 45% 45% 45% 45% 45% 45% 45% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM967852U87-EV human glioblastoma xenograft - Control 13.0880645
GSM967853U87-EV human glioblastoma xenograft - Control 23.0568145
GSM967854U87-EV human glioblastoma xenograft - Control 33.0571445
GSM967855U87-EV human glioblastoma xenograft - Control 42.9607544
GSM967856U87-EV human glioblastoma xenograft - Control 52.9728844
GSM967862U87-EV human glioblastoma xenograft - Bevacizumab treated 13.1819646
GSM967863U87-EV human glioblastoma xenograft - Bevacizumab treated 23.140746
GSM967864U87-EV human glioblastoma xenograft - Bevacizumab treated 33.0307745
GSM967865U87-EV human glioblastoma xenograft - Bevacizumab treated 43.0182345
GSM967857U87-EV human glioblastoma xenograft - dibenzazepine treated 13.0442745
GSM967858U87-EV human glioblastoma xenograft - dibenzazepine treated 23.0515845
GSM967859U87-EV human glioblastoma xenograft - dibenzazepine treated 33.0242545
GSM967860U87-EV human glioblastoma xenograft - dibenzazepine treated 43.0566545
GSM967861U87-EV human glioblastoma xenograft - dibenzazepine treated 53.0495745